This article is more than 5 years old. Information may no longer be current.

Ceterix gains $35 million in funding

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Ceterix Orthopaedics recently announced it has been granted $35 million of available borrowing capacity.

The funding comes from a new long-term loan agreement with CRG and several of its affiliate funds, according to a company press release. Further terms of the agreement were not immediately available.

“We are excited to partner with Ceterix as the company continues to advance its new technologies and improve patient outcomes in the meniscal surgery space,” Charles Tate, chairman of CRG, said in the release.

“This flexible financing will allow us to continue expanding the possibilities of meniscus repair through additional investment in innovation and clinical research,” John McCutcheon, president and CEO of Ceterix, said in the release.

Reference: www.ceterix.com.